- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 223/28 - Dibenz [b, f] azepinesHydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11
Patent holdings for IPC class C07D 223/28
Total number of patents in this class: 54
10-year publication summary
|
7
|
7
|
2
|
0
|
3
|
2
|
1
|
5
|
2
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Codexis, Inc. | 794 |
4 |
| Emory University | 1618 |
3 |
| Icahn School of Medicine at Mount Sinai | 926 |
3 |
| Kyushu University, National University Corporation | 1641 |
3 |
| Cellix Bio Private Limited | 51 |
2 |
| F.I.S. Fabbrica Italiana Sintetici S.p.A. | 123 |
2 |
| Glenmark Generics Ltd. | 36 |
2 |
| Ifom Fondazione Istituto Firc di Oncologia Molecolare | 29 |
2 |
| Kyulux, Inc. | 231 |
2 |
| Nippon Chemiphar Co., Ltd. | 229 |
2 |
| UTi Limited Partnership | 447 |
2 |
| Codagen Biosciences, Inc. | 4 |
2 |
| Massachusetts Institute of Technology | 9967 |
1 |
| The Regents of the University of Michigan | 4642 |
1 |
| University of Florida Research Foundation, Inc. | 3962 |
1 |
| Alkermes Pharma Ireland Limited | 272 |
1 |
| Board of Trustees of Michigan State University | 1177 |
1 |
| Cellixbio Private Limited | 155 |
1 |
| Dr. Reddy's Laboratories, Inc. | 184 |
1 |
| Dr. Reddy's Laboratories Limited | 559 |
1 |
| Other owners | 17 |